Clinical Trial Update: Double Carbapenem as Rescue Strategy for the Treatment of Carbapenemase-Producing Klebsiella Pneumoniae Infections

View source ↗

Summary

Clinical trial evaluating a double-carbapenem regimen as a rescue therapy for carbapenemase-producing Klebsiella pneumoniae infections; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carbapenem-resistant Klebsiella Pneumoniae Infection

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Carbapenem, Klebsiella Pneumonia | Status: COMPLETED